Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 12:40:40 +0200Thu, 15 Feb 2024 12:20:00 +0100Human medicines European public assessment report (EPAR): Praluent, alirocumab, Date of authorisation: 23/09/2015, Revision: 22, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/praluentHuman medicines European public assessment report (EPAR): Praluent, alirocumab, Date of authorisation: 23/09/2015, Revision: 22, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/praluentThu, 15 Feb 2024 12:20:00 +0100Human medicinePraluent : EPAR - Medicine overviewhttps://www.ema.europa.eu/system/files/documents/overview/h-3882-summary-en.pdfPraluent : EPAR - Medicine overviewhttps://www.ema.europa.eu/system/files/documents/overview/h-3882-summary-en.pdfThu, 04 Jan 2024 02:00:00 +0100Human medicine